A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

Beaumont Hospital

Status: Unknown

Conditions: COVID-19; Respiratory Failure; Community-acquired Pneumonia; Pulmonary Disease; Pneumonia; COPD

Treatments: Device: RespiraSense

Study type: Observational

Funder types: Other

Identifiers

NCT05384314

RespiraSense ABG investigation

Details and patient eligibility

About

A retrospective study to evaluate the predictability of abnormal arterial blood gas measurements through novel observations of continuous trends in electronically measured respiratory in a mixed cohort of respiratory compromised patients.

Enrollment: 322 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Respiratory condition is the primary admission diagnosis

Exclusion criteria

• Pregnant patients in their 2nd or 3rd trimester

Trial design

322 participants in 2 patient groups

COPD

Description:

Patients admitted with COPD as the primary admission.

Treatment:

Device: RespiraSense

Respiratory Compromised General

Description:

Patients admitted with Pneumonia, COPD, COVID, to be included

Treatment:

Device: RespiraSense